SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001012477-20-000009
Filing Date
2020-05-11
Accepted
2020-05-11 16:32:46
Documents
85
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q avdl2020q1.htm 10-Q 1296063
2 EXHIBIT 31.1 exhibit311q12020.htm EX-31.1 10237
3 EXHIBIT 31.2 exhibit312q12020.htm EX-31.2 10132
4 EXHIBIT 32.1 exhibit321q12020.htm EX-32.1 5615
5 EXHIBIT 32.2 exhibit322q12020.htm EX-32.2 5624
  Complete submission text file 0001012477-20-000009.txt   6466686

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT avdl-20200331.xml EX-101.INS 1348821
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avdl-20200331.xsd EX-101.SCH 48331
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT avdl-20200331_cal.xml EX-101.CAL 96702
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT avdl-20200331_def.xml EX-101.DEF 215413
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avdl-20200331_lab.xml EX-101.LAB 596196
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avdl-20200331_pre.xml EX-101.PRE 374135
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37977 | Film No.: 20865357
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences